Billiontoone, Inc. (NASDAQ:BLLN) Receives Average Rating of “Moderate Buy” from Analysts

Billiontoone, Inc. (NASDAQ:BLLN) has received a consensus recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $126.00.

BLLN has been the topic of several recent research reports. JPMorgan Chase & Co. boosted their target price on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Guggenheim assumed coverage on Billiontoone in a report on Monday, June 29th. They issued a “buy” rating and a $125.00 price target for the company. BTIG Research lowered their price objective on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Finally, Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd.

Billiontoone Price Performance

Shares of NASDAQ BLLN opened at $125.14 on Tuesday. The firm has a 50-day simple moving average of $105.17 and a 200-day simple moving average of $90.54. The stock has a market capitalization of $5.76 billion and a price-to-earnings ratio of 227.53. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18. Billiontoone has a 52 week low of $61.96 and a 52 week high of $138.70.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The business had revenue of $108.39 million for the quarter, compared to analyst estimates of $95.81 million. During the same quarter in the previous year, the firm posted ($0.39) earnings per share. The business’s revenue was up 83.8% compared to the same quarter last year. On average, equities analysts predict that Billiontoone will post 0.93 earnings per share for the current fiscal year.

Insider Activity

In other Billiontoone news, CTO David Tsao sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $102.27, for a total value of $2,045,400.00. Following the sale, the chief technology officer owned 1,000 shares of the company’s stock, valued at $102,270. The trade was a 95.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shan Riku Sakakibara sold 8,000 shares of the company’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $110.00, for a total value of $880,000.00. Following the transaction, the insider owned 208,000 shares in the company, valued at $22,880,000. This trade represents a 3.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 153,049 shares of company stock valued at $16,768,021 over the last three months. 50.22% of the stock is currently owned by company insiders.

Institutional Trading of Billiontoone

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Rossby Financial LCC purchased a new position in shares of Billiontoone in the fourth quarter valued at approximately $25,000. Wells Fargo & Company MN acquired a new position in shares of Billiontoone in the fourth quarter valued at approximately $76,000. Smartleaf Asset Management LLC purchased a new stake in Billiontoone during the 4th quarter worth approximately $80,000. Nano Cap New Millennium Growth Fund L P acquired a new stake in Billiontoone during the 4th quarter worth approximately $82,000. Finally, Thrive Wealth Management LLC acquired a new stake in Billiontoone during the 2nd quarter worth approximately $240,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.